Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series

Conclusions: This is the first description of the clinical use of the nasal route of administration for HAT. n-HAT may constitute an important risk-reduced rapid-onset alternative to i-HAT. In particular, it may be suited for patients with injection-related complications, or noninjecting opioid-dependent patients failing to respond to oral OAT.Eur Addict Res
Source: European Addiction Research - Category: Addiction Source Type: research